Symbols / VERV
VERV Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-08-14 08:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Lilly and Verve announce expiration of Verve tender offer - PR Newswire hu, 24 Jul 2025 07
- Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk - Eli Lilly and Company Fri, 25 Jul 2025 07
- Eli Lilly Gets Into The Gene-Editing Space With $1 Billion Takeout - Investor's Business Daily ue, 17 Jun 2025 07
- Why Verve Therapeutics Stock Is Skyrocketing Today - The Motley Fool ue, 17 Jun 2025 07
- Wall Street Analysts See a 367.86% Upside in Verve Therapeutics (VERV): Can the Stock Really Move This High? - Yahoo Finance hu, 05 Jun 2025 07
- Verve Therapeutics Stock Soars as Eli Lilly Buys Gene-Editing Firm for $1.3B - Investopedia ue, 17 Jun 2025 07
- Verve Therapeutics, Inc. (NASDAQ:VERV) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely - simplywall.st Wed, 28 May 2025 07
- What Makes Verve Therapeutics (VERV) a New Buy Stock - Nasdaq Fri, 13 Jun 2025 07
- Stocks making the biggest moves midday: Jabil, JetBlue, Sunrun, Valero, Verve Therapeutics and more - CNBC ue, 17 Jun 2025 07
- Lock In The 81.5% Run: Initiating Verve With A Sell (NASDAQ:VERV) - Seeking Alpha Wed, 18 Jun 2025 07
- Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk - Eli Lilly and Company ue, 17 Jun 2025 07
- Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week - The Motley Fool Fri, 20 Jun 2025 07
- Verve Therapeutics, Inc. (VERV): A Bull Case Theory - Yahoo Finance hu, 10 Jul 2025 07
- Verve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From Lilly - Yahoo Finance ue, 17 Jun 2025 07
- Verve Therapeutics (VERV) Reported Results From its Heart-2 Phase 1b Trial for VERVE-102 - Yahoo Finance Mon, 28 Jul 2025 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for VERV
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|